An Exploratory, Open Label, Randomized, Parallel Group Study To Investigate The Pharmacokinetics Of Single Intravenous And Oral Micro Doses Of PF-05186462, PF-05089771, PF-05241328 And PF-05150122 In Healthy Male Subjects
Phase of Trial: Phase I
Latest Information Update: 19 Feb 2016
At a glance
- Drugs PF 5089771 (Primary) ; PF 5089771 (Primary) ; PF 5141328 (Primary) ; PF 5141328 (Primary) ; PF 5150122 (Primary) ; PF 5150122 (Primary) ; PF 5186462 (Primary) ; PF 5186462 (Primary)
- Indications Pain
- Focus Adverse reactions; Pharmacokinetics
- Sponsors Pfizer
- 19 Feb 2016 Results of two phase I studies published in the Clinical Pharmacokinetics.
- 23 Aug 2010 Status changed from recruiting to completed as reported by ClinicalTrials.gov.
- 10 Aug 2010 Actual initiation date added to 1 Jul 2010 as reported by ClinicalTrials.gov.